These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21305005)

  • 1. A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers.
    Hunt PW; Landay AL; Sinclair E; Martinson JA; Hatano H; Emu B; Norris PJ; Busch MP; Martin JN; Brooks C; McCune JM; Deeks SG
    PLoS One; 2011 Jan; 6(1):e15924. PubMed ID: 21305005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.
    Hunt PW; Brenchley J; Sinclair E; McCune JM; Roland M; Page-Shafer K; Hsue P; Emu B; Krone M; Lampiris H; Douek D; Martin JN; Deeks SG
    J Infect Dis; 2008 Jan; 197(1):126-33. PubMed ID: 18171295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers.
    Hunt PW; Hatano H; Sinclair E; Lee TH; Busch MP; Martin JN; McCune JM; Deeks SG
    Clin Infect Dis; 2011 Mar; 52(5):681-7. PubMed ID: 21245154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.
    Owen RE; Heitman JW; Hirschkorn DF; Lanteri MC; Biswas HH; Martin JN; Krone MR; Deeks SG; Norris PJ;
    AIDS; 2010 May; 24(8):1095-105. PubMed ID: 20400885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment.
    Emu B; Sinclair E; Favre D; Moretto WJ; Hsue P; Hoh R; Martin JN; Nixon DF; McCune JM; Deeks SG
    J Virol; 2005 Nov; 79(22):14169-78. PubMed ID: 16254352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS.
    Gonzalez SM; Taborda NA; Correa LA; Castro GA; Hernandez JC; Montoya CJ; Rugeles MT
    Immunol Res; 2016 Jun; 64(3):765-74. PubMed ID: 26724942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal.
    Legrand FA; Nixon DF; Loo CP; Ono E; Chapman JM; Miyamoto M; Diaz RS; Santos AM; Succi RC; Abadi J; Rosenberg MG; de Moraes-Pinto MI; Kallas EG
    PLoS One; 2006 Dec; 1(1):e102. PubMed ID: 17183635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR expression on regulatory T cells is closely associated with the global immune activation in HIV-1 infected subjects naïve to antiretroviral therapy.
    Xiao J; Qian KL; Cao QH; Qiu CL; Qiu C; Xue YL; Zhang XY; Zhong P; Xu JQ; Li MY; Wang Y
    Chin Med J (Engl); 2011 Aug; 124(15):2340-6. PubMed ID: 21933566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A correlate of HIV-1 control consisting of both innate and adaptive immune parameters best predicts viral load by multivariable analysis in HIV-1 infected viremic controllers and chronically-infected non-controllers.
    Tomescu C; Liu Q; Ross BN; Yin X; Lynn K; Mounzer KC; Kostman JR; Montaner LJ
    PLoS One; 2014; 9(7):e103209. PubMed ID: 25078947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete normalization of regulatory t-cell frequency in the gut mucosa of Colombian HIV-infected patients receiving long-term antiretroviral treatment.
    Rueda CM; Velilla PA; Chougnet CA; Rugeles MT
    PLoS One; 2013; 8(8):e71062. PubMed ID: 23967152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
    J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 elite controllers present a high frequency of activated regulatory T and Th17 cells.
    Caetano DG; de Paula HHS; Bello G; Hoagland B; Villela LM; Grinsztejn B; Veloso VG; Morgado MG; Guimarães ML; Côrtes FH
    PLoS One; 2020; 15(2):e0228745. PubMed ID: 32023301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8
    Fenoglio D; Dentone C; Signori A; Di Biagio A; Parodi A; Kalli F; Nasi G; Curto M; Cenderello G; De Leo P; Bartolacci V; Orofino G; Nicolini LA; Taramasso L; Fiorillo E; Orrù V; Traverso P; Bruzzone B; Ivaldi F; Mantia E; Guerra M; Negrini S; Giacomini M; Bhagani S; Filaci G
    J Allergy Clin Immunol; 2018 Jun; 141(6):2220-2233.e4. PubMed ID: 29103633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.
    Shaw JM; Hunt PW; Critchfield JW; McConnell DH; Garcia JC; Pollard RB; Somsouk M; Deeks SG; Shacklett BL
    J Virol; 2011 Nov; 85(21):11422-34. PubMed ID: 21880771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy.
    Weiss L; Piketty C; Assoumou L; Didier C; Caccavelli L; Donkova-Petrini V; Levy Y; Girard PM; Burgard M; Viard JP; Rouzioux C; Costagliola D;
    PLoS One; 2010 Jul; 5(7):e11659. PubMed ID: 20657770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral Therapy Reduces T-cell Activation and Immune Exhaustion Markers in Human Immunodeficiency Virus Controllers.
    Li JZ; Segal FP; Bosch RJ; Lalama CM; Roberts-Toler C; Delagreverie H; Getz R; Garcia-Broncano P; Kinslow J; Tressler R; Van Dam CN; Keefer M; Carrington M; Lichterfeld M; Kuritzkes D; Yu XG; Landay A; Sax PE;
    Clin Infect Dis; 2020 Apr; 70(8):1636-1642. PubMed ID: 31131858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study.
    Potter SJ; Lacabaratz C; Lambotte O; Perez-Patrigeon S; Vingert B; Sinet M; Colle JH; Urrutia A; Scott-Algara D; Boufassa F; Delfraissy JF; Thèze J; Venet A; Chakrabarti LA
    J Virol; 2007 Dec; 81(24):13904-15. PubMed ID: 17928341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV controllers are distinguished by chemokine expression profile and HIV-specific T-cell proliferative potential.
    Card CM; Keynan Y; Lajoie J; Bell CP; Dawood M; Becker M; Kasper K; Fowke KR
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):427-37. PubMed ID: 22240463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation.
    Shaw JM; Hunt PW; Critchfield JW; McConnell DH; Garcia JC; Pollard RB; Somsouk M; Deeks SG; Shacklett BL
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):172-7. PubMed ID: 22998457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helios + Regulatory T cell frequencies are correlated with control of viral replication and recovery of absolute CD4 T cells counts in early HIV-1 infection.
    Matavele Chissumba R; Namalango E; Maphossa V; Macicame I; Bhatt N; Polyak C; Robb M; Michael N; Jani I; Kestens L
    BMC Immunol; 2017 Dec; 18(1):50. PubMed ID: 29246111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.